Skip to main content
Gencurix Inc. logo

Gencurix Inc. — Investor Relations & Filings

Ticker · 229000 ISIN · KR7229000005 KO Manufacturing
Open in API
Filings indexed 405 across all filing types
Latest filing 2023-01-27 Capital/Financing Update
Country KR South Korea
Listing KO 229000

About Gencurix Inc.

https://www.gencurix.com/eng/

Gencurix Inc. is a molecular diagnostics company that develops and commercializes diagnostic solutions for precision medicine. The company's portfolio focuses primarily on oncology, offering prognostic, companion, and early detection tests. Key products include GenesWell BCT, a multigene prognostic test for early-stage breast cancer, and the GenesWell ddEGFR Mutation Test, a ddPCR-based companion diagnostic. Gencurix also utilizes its Droplex liquid biopsy platform for early cancer detection and develops diagnostic tests for infectious diseases. The company's core technologies include digital droplet PCR (ddPCR), real-time PCR, and liquid biopsy for analyzing circulating tumor cells (CTCs) and cell-free DNA (cfDNA).

Recent filings

Filing Released Lang Actions
[기재정정]증권신고서(지분증권) (2023.04)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) amendment (정정신고) filed by Gencurix (젠큐릭스). It details corrections made to a previously filed securities registration statement, including updates to offering methods, risk factors, and financial disclosures, following a request from the Financial Supervisory Service (FSS). This type of document is a formal regulatory filing related to capital raising (equity issuance) and does not fit into the specific categories of annual reports, earnings releases, or proxy statements. It is classified as a Regulatory Filing (RNS) as it is a formal submission to a regulatory body regarding a capital-related process.
2023-01-27 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Gencurix, specifically detailing a decision for a paid-in capital increase (유상증자결정). This document outlines the terms of the capital raise, including share issuance, pricing, allocation methods, and use of proceeds. According to the filing definitions, announcements regarding new share issues or capital changes are classified as 'SHA'.
2023-01-16 Korean
증권신고서(지분증권) (2023.04)
Investor Presentation Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed with the Financial Services Commission (FSC) in South Korea. It details a capital increase (유상증자) through a rights offering, including information on the number of shares, offering price, and detailed risk factors (business, financial, and management risks). This document is a formal regulatory filing required for public offerings of securities, which falls under the 'Regulatory Filings' category as it is a primary disclosure document for capital raising.
2023-01-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. This document details changes in share ownership by major shareholders and special related parties (directors/executives). Based on the provided filing categories, this corresponds to a 'Major Shareholding Notification' (MRQ).
2023-01-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required by the Financial Services Commission and the Korea Exchange when an entity's shareholding in a listed company crosses certain thresholds. This document specifically details the shareholding changes of Timefolio Asset Management in Gencurix. In the context of financial reporting, this is classified as a Major Shareholding Notification (MRQ).
2022-12-20 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It does not contain the full AGM materials or the meeting results, but rather serves as a formal regulatory announcement of the upcoming meeting logistics. As it does not fit into specific categories like AGM-R (presentations) or DVA (voting results), and is a standard regulatory disclosure, it is classified as a general regulatory filing.
2022-12-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.